- Home
- KRMD vs THTX Comparison
KRMD vs THTX Comparison
Compare KRMD & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- THTX
- Stock Information
- Founded
- KRMD 1980
- THTX 1993
- Country
- KRMD United States
- THTX Canada
- Employees
- KRMD N/A
- THTX N/A
- Industry
- KRMD Medical/Dental Instruments
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- THTX Health Care
- Exchange
- KRMD Nasdaq
- THTX Nasdaq
- Market Cap
- KRMD 134.3M
- THTX 144.8M
- IPO Year
- KRMD N/A
- THTX N/A
- Fundamental
- Price
- KRMD $4.17
- THTX $3.24
- Analyst Decision
- KRMD Strong Buy
- THTX Hold
- Analyst Count
- KRMD 4
- THTX 1
- Target Price
- KRMD $4.63
- THTX N/A
- AVG Volume (30 Days)
- KRMD 131.8K
- THTX 249.2K
- Earning Date
- KRMD 08-06-2025
- THTX 10-09-2025
- Dividend Yield
- KRMD N/A
- THTX N/A
- EPS Growth
- KRMD N/A
- THTX N/A
- EPS
- KRMD N/A
- THTX N/A
- Revenue
- KRMD $36,848,451.00
- THTX $84,378,000.00
- Revenue This Year
- KRMD $18.16
- THTX N/A
- Revenue Next Year
- KRMD $14.60
- THTX $13.76
- P/E Ratio
- KRMD N/A
- THTX N/A
- Revenue Growth
- KRMD 19.57
- THTX 2.19
- 52 Week Low
- KRMD $1.86
- THTX $1.12
- 52 Week High
- KRMD $5.05
- THTX $3.25
- Technical
- Relative Strength Index (RSI)
- KRMD 66.43
- THTX 74.26
- Support Level
- KRMD $4.08
- THTX $3.18
- Resistance Level
- KRMD $4.34
- THTX $3.22
- Average True Range (ATR)
- KRMD 0.22
- THTX 0.02
- MACD
- KRMD 0.07
- THTX -0.01
- Stochastic Oscillator
- KRMD 85.09
- THTX 90.00
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.